azathioprine has been researched along with Eczema, Atopic in 77 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Azathioprine is frequently used in severe eczema." | 7.88 | Thiopurine metabolite levels in patients with atopic dermatitis and/or chronic hand/foot eczema treated with azathioprine. ( Bruijnzeel-Koomen, CAF; de Bruin-Weller, MS; de Graaf, M; Garritsen, FM; van den Broek, MPH; van der Schaft, J; van Schaik, RH, 2018) |
| "Azathioprine is frequently used in severe eczema." | 3.88 | Thiopurine metabolite levels in patients with atopic dermatitis and/or chronic hand/foot eczema treated with azathioprine. ( Bruijnzeel-Koomen, CAF; de Bruin-Weller, MS; de Graaf, M; Garritsen, FM; van den Broek, MPH; van der Schaft, J; van Schaik, RH, 2018) |
| "We present a case of drug-induced alveolitis following infliximab and azathioprine for the treatment of severe, generalised psoriasis and atopic eczema without pre-existing lung disease." | 3.74 | [Drug-induced alveolitis associated with infliximab/azathioprine therapy]. ( Dercken, HG; El-Hag, K; Hölzle, E; Prenzel, R, 2008) |
| " He had CD4 lymphocytopenia during azathioprine and topical corticosteroid therapy for atopic dermatitits (AD)." | 3.69 | Kaposi's sarcoma during immunosuppressive therapy for atopic dermatitis. ( Janssens, P; Lachapelle, JM; Lambert, M; Tennstedt, D; Vandercam, B, 1997) |
| "Azathioprine has an important role in treatment of many inflammatory dermatoses." | 3.69 | Azathioprine in dermatology: a survey of current practice in the U.K. ( English, JS; Gawkrodger, DJ; Lear, JT; Tan, BB, 1997) |
| "Azathioprine is an accessible drug for patients in many countries, including underdeveloped countries, and therefore it is used by many dermatologists in moderate and severe AD." | 2.82 | The use of azathioprine in atopic dermatitis: A review. ( Bracho-Borro, M; Franco-Ruiz, PA; Magaña, M, 2022) |
| "Patients with severe atopic eczema frequently require systemic treatment to control their disease." | 2.76 | A randomized trial of methotrexate versus azathioprine for severe atopic eczema. ( Bos, JD; Leeflang, MM; Roekevisch, E; Schmitt, J; Schram, ME; Spuls, PI, 2011) |
| " TPMT-based dosing seemed to reduce predicted toxicity, and drug efficacy was maintained." | 2.72 | Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. ( Gray, JC; Meggitt, SJ; Reynolds, NJ, 2006) |
| "Leukopenia was observed in two patients and deranged liver enzymes in eight during treatment with azathioprine." | 2.70 | Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. ( Agarwal, S; Ahmed, I; Barclay, G; Berth-Jones, J; Graham-Brown, RA; Hotchkiss, K; Takwale, A; Tan, E, 2002) |
| "Atopic dermatitis is a common, chronic pruritic condition affecting both children and adults, which has a negative impact on the quality of life." | 2.53 | Guidelines for the Management of Atopic Dermatitis in Singapore. ( Chan, YC; Chandran, NS; Ho, MS; Koh, MJ; Lim, YL; Tang, MB; Tay, YK; Thirumoorthy, T, 2016) |
| " Safety data were compared by calculating the weekly incidence rates (as percentages) for adverse events." | 2.50 | Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. ( Kuester, D; Limpens, J; Roekevisch, E; Schmitt, J; Spuls, PI, 2014) |
| "The optimal treatment of atopic dermatitis requires regular medical supervision." | 2.42 | [Systemic therapy of atopic dermatitis]. ( Breuer, K; Heratizadeh, A; Kapp, A; Werfel, T, 2003) |
| " The mean initial dosage of AZA was 1." | 1.51 | A Retrospective Study of Systemic Treatment of Severe Atopic Dermatitis With Azathioprine: Effectiveness and Tolerance in 11 Pediatric Patients. ( Hernández-Martín, A; Knöpfel, N; Noguera-Morel, L; Torrelo, A, 2019) |
| "Oral azathioprine was associated with few pronounced adverse effects for the duration of use and dosage in this cohort." | 1.42 | The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring. ( Bragoli, W; Fuggle, NR; Glover, M; Kinsler, VA; Mahto, A; Martinez, AE, 2015) |
| "Atopic dermatitis is the most common chronic inflammatory skin disease with high prevalence rates in adults and even higher among children." | 1.42 | The anti-IL-4 receptor alpha antibody dupilumab: facing a new era in treating atopic dermatitis. ( Luger, TA; Tsianakas, A, 2015) |
| "In this third of 4 sections, treatment of atopic dermatitis with phototherapy and systemic immunomodulators, antimicrobials, and antihistamines is reviewed, including indications for use and the risk-benefit profile of each treatment option." | 1.40 | Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. ( Begolka, WS; Berger, TG; Bergman, JN; Block, J; Chamlin, SL; Cohen, DE; Cooper, KD; Cordoro, KM; Davis, DM; Eichenfield, LF; Elmets, CA; Feldman, SR; Hanifin, JM; Harrod, CG; Krol, A; Margolis, DJ; Paller, AS; Schwarzenberger, K; Sidbury, R; Silverman, RA; Simpson, EL; Tom, WL; Williams, HC, 2014) |
| "Azathioprine therapy was associated with clinical improvement in all but 1 patient." | 1.39 | Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring. ( Caufield, M; Tom, WL, 2013) |
| "Our experience shows that, when adjusted to thiopurine methyltransferase activity, azathioprine is a safe drug for the treatment of children with severe atopic dermatitis." | 1.36 | [Safety of azathioprine therapy adjusted to thiopurine methyltransferase activity in the treatment of infantile atopic dermatitis. Report on 7 cases]. ( Borrego, L; Islas, D; Martel, RM; Melwani, P; Peñate, Y, 2010) |
| "Azathioprine was stopped in one female after 4 months due to lack of efficacy." | 1.35 | Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults. ( Ching, GK; Chow, CM; Hon, KL; Lee, KK; Leung, TF; Ng, PC, 2009) |
| "A 61-year-old Chinese man with severe atopic eczema developed moderate myelosuppression with standard doses of azathioprine." | 1.35 | TPMT*26 (208F-->L), a novel mutation detected in a Chinese. ( Aw, DC; Kham, SK; Soh, CK; Yeoh, AE, 2009) |
| "We suggest that food hypersensitivity should be ruled out in patients with hypereosinophilia, hyper-IgE syndrome, and atopic dermatitis." | 1.35 | Hypereosinophilia, hyper-IgE syndrome, and atopic dermatitis in a toddler with food hypersensitivity. ( Estrada-Reyes, E; Gamboa-Marrufo, JD; Hernnández-Román, MP; Nava-Ocampo, AA; Valencia-Herrera, A, 2008) |
| "Effective treatment of severe adult atopic eczema may necessitate the use of agents such as systemic steroids, PUVA or cyclosporin, which are associated with significant morbidity." | 1.30 | The use of azathioprine in severe adult atopic eczema. ( Baldwin, P; Buckley, DA; Rogers, S, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (5.19) | 18.7374 |
| 1990's | 6 (7.79) | 18.2507 |
| 2000's | 17 (22.08) | 29.6817 |
| 2010's | 43 (55.84) | 24.3611 |
| 2020's | 7 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bracho-Borro, M | 1 |
| Franco-Ruiz, PA | 1 |
| Magaña, M | 1 |
| de Graaf, M | 3 |
| Janmohamed, SR | 1 |
| Schuttelaar, MLA | 1 |
| Agner, T | 2 |
| Alfonso, JH | 1 |
| De Schepper, S | 1 |
| Deleuran, M | 2 |
| Despontin, K | 1 |
| Elenius, V | 1 |
| Ghislain, PD | 1 |
| Huilaja, L | 1 |
| Johansson, EK | 1 |
| Kvenshagen, BK | 1 |
| Mandelin, JM | 1 |
| Olset, H | 1 |
| Svensson, A | 2 |
| van Tuyll van Serooskerken, AM | 1 |
| Thyssen, JP | 1 |
| Vestergaard, C | 2 |
| Wollenberg, A | 1 |
| Kinberger, M | 1 |
| Arents, B | 1 |
| Aszodi, N | 1 |
| Avila Valle, G | 1 |
| Barbarot, S | 1 |
| Bieber, T | 3 |
| Brough, HA | 1 |
| Calzavara Pinton, P | 1 |
| Christen-Zäch, S | 1 |
| Dittmann, M | 1 |
| Dressler, C | 1 |
| Fink-Wagner, AH | 1 |
| Fosse, N | 1 |
| Gáspár, K | 1 |
| Gerbens, L | 1 |
| Gieler, U | 1 |
| Girolomoni, G | 1 |
| Gregoriou, S | 1 |
| Mortz, CG | 1 |
| Nast, A | 1 |
| Nygaard, U | 1 |
| Redding, M | 1 |
| Rehbinder, EM | 1 |
| Ring, J | 1 |
| Rossi, M | 1 |
| Serra-Baldrich, E | 1 |
| Simon, D | 2 |
| Szalai, ZZ | 1 |
| Szepietowski, JC | 1 |
| Torrelo, A | 2 |
| Werfel, T | 3 |
| Flohr, C | 5 |
| Cheirif-Wolosky, O | 1 |
| Elizalde-Jiménez, IG | 1 |
| Romero, MTG | 1 |
| Singh, P | 1 |
| Silverberg, JI | 1 |
| Drucker, AM | 1 |
| Ellis, AG | 1 |
| Bohdanowicz, M | 1 |
| Mashayekhi, S | 1 |
| Yiu, ZZN | 1 |
| Rochwerg, B | 1 |
| Di Giorgio, S | 1 |
| Arents, BWM | 1 |
| Burton, T | 1 |
| Spuls, PI | 7 |
| Küster, D | 1 |
| Siegels, D | 1 |
| Schmitt, J | 5 |
| Pino Lopez, J | 1 |
| Kromer, C | 1 |
| Herr, R | 1 |
| Schmieder, A | 1 |
| Bayerl, C | 1 |
| Schaarschmidt, ML | 1 |
| Prezzano, JC | 1 |
| Beck, LA | 3 |
| Davis, DM | 2 |
| Borok, J | 1 |
| Udkoff, J | 1 |
| Lio, P | 1 |
| Spergel, J | 1 |
| Garritsen, FM | 4 |
| van der Schaft, J | 5 |
| Bruijnzeel-Koomen, CAF | 2 |
| van Schaik, RH | 2 |
| van den Broek, MPH | 3 |
| de Bruin-Weller, MS | 6 |
| Roekevisch, E | 6 |
| Schram, ME | 3 |
| Leeflang, MMG | 3 |
| Brouwer, MWD | 2 |
| Gerbens, LAA | 2 |
| Bos, JD | 3 |
| Hijnen, DJ | 1 |
| Hamann, SAS | 1 |
| Lacour, JP | 1 |
| van den Heuvel, JM | 1 |
| Bruijnzeel-Koomen, CAFM | 1 |
| Maitland-van der Zee, AH | 1 |
| Ordóñez Rubiano, MF | 1 |
| Arenas, CM | 1 |
| Chalela, JG | 1 |
| von Kobyletzki, LB | 1 |
| Weidinger, S | 2 |
| Kabashima, K | 1 |
| Irvine, AD | 2 |
| Noguera-Morel, L | 1 |
| Knöpfel, N | 1 |
| Hernández-Martín, A | 1 |
| Vicente Villa, A | 1 |
| Solman, L | 1 |
| Lloyd-Lavery, A | 1 |
| Grindlay, DJC | 1 |
| Rogers, NK | 1 |
| Thomas, KS | 1 |
| Harman, KE | 1 |
| Alexander, H | 1 |
| Patton, T | 1 |
| Jabbar-Lopez, ZK | 1 |
| Manca, A | 1 |
| Kuester, D | 1 |
| Limpens, J | 1 |
| Sidbury, R | 2 |
| Cohen, DE | 1 |
| Cordoro, KM | 1 |
| Berger, TG | 1 |
| Bergman, JN | 1 |
| Chamlin, SL | 1 |
| Cooper, KD | 1 |
| Feldman, SR | 1 |
| Hanifin, JM | 1 |
| Krol, A | 1 |
| Margolis, DJ | 1 |
| Paller, AS | 2 |
| Schwarzenberger, K | 1 |
| Silverman, RA | 1 |
| Simpson, EL | 1 |
| Tom, WL | 2 |
| Williams, HC | 1 |
| Elmets, CA | 1 |
| Block, J | 1 |
| Harrod, CG | 1 |
| Begolka, WS | 1 |
| Eichenfield, LF | 2 |
| Thomsen, SF | 1 |
| Karlsmark, T | 1 |
| Clemmensen, KK | 1 |
| Graversgaard, C | 1 |
| Ibler, KS | 1 |
| Jemec, GB | 1 |
| Fuggle, NR | 1 |
| Bragoli, W | 1 |
| Mahto, A | 1 |
| Glover, M | 1 |
| Martinez, AE | 1 |
| Kinsler, VA | 1 |
| Deinum, J | 1 |
| van den Broek, MP | 1 |
| Bruijnzeel-Koomen, CA | 2 |
| Tsianakas, A | 1 |
| Luger, TA | 1 |
| Notaro, ER | 1 |
| Politiek, K | 1 |
| van den Reek, JM | 1 |
| Kievit, W | 1 |
| de Jong, EM | 1 |
| Schuttelaar, ML | 1 |
| Védie, AL | 1 |
| Ezzedine, K | 1 |
| Amazan, E | 1 |
| Boralevi, F | 1 |
| Milpied, B | 1 |
| Taïeb, A | 1 |
| Seneschal, J | 1 |
| Bagherani, N | 1 |
| Smoller, BR | 1 |
| Tan, SH | 1 |
| Yew, YW | 1 |
| Tay, YK | 1 |
| Chan, YC | 1 |
| Chandran, NS | 1 |
| Ho, MS | 1 |
| Koh, MJ | 1 |
| Lim, YL | 1 |
| Tang, MB | 1 |
| Thirumoorthy, T | 1 |
| Riis, JL | 1 |
| Hjuler, KF | 1 |
| Iversen, L | 1 |
| Jakobsen, L | 1 |
| Deleuran, MS | 1 |
| Olsen, M | 1 |
| Totri, CR | 1 |
| Logan, K | 1 |
| Proudfoot, L | 1 |
| Lara-Corrales, I | 1 |
| Sugarman, J | 1 |
| Tom, W | 1 |
| Siegfried, E | 1 |
| Cordoro, K | 1 |
| Abraham, S | 1 |
| Trautmann, F | 1 |
| Stephan, V | 1 |
| Fölster-Holst, R | 1 |
| Homey, B | 1 |
| Novak, N | 1 |
| Sticherling, M | 1 |
| Augustin, M | 1 |
| Kleinheinz, A | 1 |
| Elsner, P | 1 |
| Campbell, LE | 1 |
| Irwin McLean, WH | 1 |
| Kezic, S | 1 |
| Middelkamp-Hup, MA | 1 |
| Chong, JH | 1 |
| Koh, MJA | 1 |
| Hughes, R | 1 |
| Collins, P | 1 |
| Rogers, S | 2 |
| Hon, KL | 1 |
| Ching, GK | 1 |
| Leung, TF | 1 |
| Chow, CM | 1 |
| Lee, KK | 1 |
| Ng, PC | 1 |
| Wolverton, SE | 1 |
| Kham, SK | 1 |
| Soh, CK | 1 |
| Aw, DC | 1 |
| Yeoh, AE | 1 |
| Shaw, MG | 1 |
| Burkhart, CN | 1 |
| Morrell, DS | 1 |
| Martel, RM | 1 |
| Melwani, P | 1 |
| Islas, D | 1 |
| Peñate, Y | 1 |
| Borrego, L | 1 |
| Lai, SW | 1 |
| Wang, YC | 1 |
| Wang, CH | 1 |
| Huang, TY | 1 |
| Wee, JS | 1 |
| Marinaki, A | 1 |
| Smith, CH | 1 |
| Thiryayi, WA | 1 |
| Leeflang, MM | 1 |
| Denby, KS | 1 |
| Caufield, M | 1 |
| Tan, AU | 1 |
| Gonzalez, ME | 1 |
| Murphy, LA | 1 |
| Atherton, D | 1 |
| Berth-Jones, J | 1 |
| Takwale, A | 1 |
| Tan, E | 1 |
| Barclay, G | 1 |
| Agarwal, S | 1 |
| Ahmed, I | 1 |
| Hotchkiss, K | 1 |
| Graham-Brown, RA | 1 |
| Heratizadeh, A | 1 |
| Breuer, K | 1 |
| Kapp, A | 1 |
| Malthieu, F | 1 |
| Guillet, G | 1 |
| Larregue, M | 1 |
| Bodemer, C | 1 |
| Bernier, C | 1 |
| Meggitt, SJ | 2 |
| Gray, JC | 1 |
| Reynolds, NJ | 2 |
| Favrot, C | 1 |
| Reichmuth, P | 1 |
| Olivry, T | 1 |
| El-Hag, K | 1 |
| Dercken, HG | 1 |
| Prenzel, R | 1 |
| Hölzle, E | 1 |
| Estrada-Reyes, E | 1 |
| Hernnández-Román, MP | 1 |
| Gamboa-Marrufo, JD | 1 |
| Valencia-Herrera, A | 1 |
| Nava-Ocampo, AA | 1 |
| Lear, JT | 2 |
| English, JS | 2 |
| Jones, P | 1 |
| Smith, AG | 1 |
| Vandercam, B | 1 |
| Lachapelle, JM | 1 |
| Janssens, P | 1 |
| Tennstedt, D | 1 |
| Lambert, M | 1 |
| Tan, BB | 1 |
| Gawkrodger, DJ | 1 |
| Buckley, DA | 1 |
| Baldwin, P | 1 |
| Lyons, F | 1 |
| Kuanprasert, N | 1 |
| Herbert, O | 1 |
| Barnetson, RS | 1 |
| Numata, T | 1 |
| Mizuno, N | 1 |
| Russell Jones, R | 1 |
| Anderson, C | 1 |
| Gunnar, S | 1 |
| Johansson, O | 1 |
| Juhlin, L | 1 |
| Thomas, F | 1 |
| Owens, L | 1 |
| Thomas, J | 1 |
| Wolf, JS | 1 |
| Volk, M | 1 |
| Mendez, G | 1 |
| Lee, HM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Baricitinib Versus Azathioprine in Combination With Topical Corticosteroids For Patients With Moderate-to-Severe Atopic Dermatitis[NCT05969730] | 40 participants (Anticipated) | Interventional | 2023-08-15 | Recruiting | |||
| Effects of Abrocitinib Treatment of Moderate to Severe Atopic Dermatitis on Skin Barrier Function[NCT05140239] | 20 participants (Anticipated) | Observational | 2022-09-01 | Recruiting | |||
| A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Parallel-Group, Nutritional Intervention Study to Examine the Clinical and Immunological Effects of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed[NCT04662619] | 273 participants (Actual) | Interventional | 2020-12-18 | Active, not recruiting | |||
| Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis: A Randomized, Single-blinded, Prospective Crossover Controlled Trial[NCT03397979] | 63 participants (Actual) | Interventional | 2011-11-14 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
19 reviews available for azathioprine and Eczema, Atopic
| Article | Year |
|---|---|
The use of azathioprine in atopic dermatitis: A review.
Topics: Azathioprine; Dermatitis, Atopic; Drug-Related Side Effects and Adverse Reactions; Humans; Immunosup | 2022 |
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis.
Topics: Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclosporine; Dermatitis, Atopic; Dermatolog | 2020 |
Long-Term Treatment of Atopic Dermatitis.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Azathioprine; Baths; Calcineurin Inhibitors; Cyc | 2017 |
Atopic dermatitis: phototherapy and systemic therapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclosporine; Dermatitis, A | 2017 |
Atopic dermatitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com | 2018 |
Atopic dermatitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com | 2018 |
Atopic dermatitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com | 2018 |
Atopic dermatitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com | 2018 |
What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 1: treatment and prevention.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Anti-Allergic Agents; Azathi | 2019 |
Novel systemic therapies in atopic dermatitis: what do we need to fulfil the promise of a treatment revolution?
Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Randomized Controlled Trials a | 2019 |
Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Glucocorticoids; Humans; Immunosuppressive Agents; I | 2014 |
Systemic Agents for Severe Atopic Dermatitis in Children.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; | 2015 |
Guidelines for the Management of Atopic Dermatitis in Singapore.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Anti-Bacterial Agents; Azathioprine; Calcineurin | 2016 |
Non-topical management of recalcitrant paediatric atopic dermatitis.
Topics: Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunosuppressiv | 2017 |
Systemic therapies for pediatric atopic dermatitis: a review for the primary care physician.
Topics: Algorithms; Anti-Bacterial Agents; Antiviral Agents; Azathioprine; Child; Child, Preschool; Cyclospo | 2009 |
Systemic therapy of atopic dermatitis in children and adults.
Topics: Adrenal Cortex Hormones; Adult; Alitretinoin; Antibodies, Monoclonal; Azathioprine; Child; Cyclospor | 2011 |
Update on systemic therapies for atopic dermatitis.
Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Enzyme Inhibitors; Female; Humans; Immunosuppressive | 2012 |
Management of severe atopic dermatitis in children.
Topics: Administration, Cutaneous; Adolescent; Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine | 2012 |
[Systemic therapy of atopic dermatitis].
Topics: Adjuvants, Immunologic; Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Animals; Anti-Bacte | 2003 |
[How should severe and chronic atopic dermatitis in children be managed?].
Topics: Azathioprine; Child; Chronic Disease; Dermatitis, Atopic; Humans; Immunologic Factors; Immunosuppres | 2005 |
[How should severe and chronic atopic dermatitis be managed in children?].
Topics: Azathioprine; Child; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Humans; Immunologic Factors; | 2005 |
Azathioprine for atopic dermatitis.
Topics: Azathioprine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunosuppressive Agents; Mercaptopur | 2001 |
7 trials available for azathioprine and Eczema, Atopic
| Article | Year |
|---|---|
Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Dermatologic Agents; Drug Administration Schedule; Drug Sub | 2018 |
Patients with atopic dermatitis with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Female; Filaggrin Proteins; Humans; Immunosuppressive Agent | 2017 |
A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; Methotrexat | 2011 |
Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial.
Topics: Adolescent; Adult; Aged; Azathioprine; Cross-Over Studies; Dermatitis, Atopic; Double-Blind Method; | 2002 |
[Azatropin in severe atopic dermatitis: 24 cases].
Topics: Adult; Azathioprine; Child; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; Retr | 2005 |
Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
Topics: Adolescent; Adult; Aged; Azathioprine; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Immu | 2006 |
Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
Topics: Adolescent; Adult; Aged; Azathioprine; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Immu | 2006 |
Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
Topics: Adolescent; Adult; Aged; Azathioprine; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Immu | 2006 |
Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
Topics: Adolescent; Adult; Aged; Azathioprine; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Immu | 2006 |
Treatment of canine atopic dermatitis with azathioprine: a pilot study.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Azathioprine; Dermatitis, Atopic; Dog Diseases; | 2007 |
51 other studies available for azathioprine and Eczema, Atopic
| Article | Year |
|---|---|
Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe.
Topics: Adolescent; Azathioprine; Biological Products; Child; Child, Preschool; Cyclosporine; Delphi Techniq | 2022 |
European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy.
Topics: Adolescent; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Immunosuppressive | 2022 |
Systemic treatment for severe atopic dermatitis in children: a case series.
Topics: Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Mycop | 2022 |
Adverse event monitoring in patients on oral systemic medications for inflammatory skin disease.
Topics: Azathioprine; Cross-Sectional Studies; Cyclosporine; Dermatitis, Atopic; Drug Eruptions; Drug Monito | 2020 |
Drug survival rates and reasons for drug discontinuation in patients with atopic dermatitis: a retrospective study of adult outpatients.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Child, Preschool; C | 2021 |
Thiopurine metabolite levels in patients with atopic dermatitis and/or chronic hand/foot eczema treated with azathioprine.
Topics: Adult; Azathioprine; Chromatography, High Pressure Liquid; Dermatitis, Atopic; Eczema; Female; Guani | 2018 |
Methotrexate versus azathioprine in patients with atopic dermatitis: 2-year follow-up data.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Female; Filaggrin Proteins; Follow-Up Studies; Humans; Inte | 2018 |
Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema.
Topics: Adult; Allopurinol; Azathioprine; Chronic Disease; Dermatitis, Atopic; Drug Therapy, Combination; Ec | 2018 |
[Current and upcoming treatments of adult atopic dermatitis].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Boron Compounds; Bri | 2017 |
Use of oral immunosuppressive drugs in the treatment of atopic dermatitis in the Netherlands.
Topics: Administration, Oral; Azathioprine; Cyclosporine; Databases, Factual; Dermatitis, Atopic; Drug Presc | 2018 |
UVA-1 phototherapy for the management of atopic dermatitis: a large retrospective study conducted in a low-middle income country.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Colombia; Dermatitis, Atopic; Develo | 2018 |
Building the evidence base for current systemic treatments for severe, chronic atopic dermatitis: methotrexate vs. azathioprine.
Topics: Azathioprine; Dermatitis, Atopic; Follow-Up Studies; Humans; Methotrexate; Mycophenolic Acid | 2018 |
A Retrospective Study of Systemic Treatment of Severe Atopic Dermatitis With Azathioprine: Effectiveness and Tolerance in 11 Pediatric Patients.
Topics: Adolescent; Azathioprine; Child; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; | 2019 |
Azathioprine in the Treatment of Severe Pediatric Atopic Dermatitis: Experience in a Referral Hospital in Spain.
Topics: Azathioprine; Dermatitis, Atopic; Humans; Referral and Consultation; Spain | 2019 |
Systemic therapies for severe atopic dermatitis in children and adults.
Topics: Adult; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Male | 2013 |
Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.
Topics: Anti-Infective Agents; Azathioprine; Cyclosporine; Dermatitis, Atopic; Histamine Antagonists; Humans | 2014 |
Outcome of treatment with azathioprine in severe atopic dermatitis: a 5-year retrospective study of adult outpatients.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Dermatologic Agents; Drug Administration Schedule; Female; | 2015 |
The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring.
Topics: Administration, Oral; Azathioprine; Child; Dermatitis, Atopic; Drug Monitoring; Drug-Related Side Ef | 2015 |
Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
Topics: Academic Medical Centers; Administration, Oral; Adult; Azathioprine; Cyclosporine; Dermatitis, Atopi | 2015 |
Increased liver enzyme levels during azathioprine treatment: beware of concomitant use of proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Alanine Transaminase; Azathioprine; Dermatitis, Atopi | 2015 |
The anti-IL-4 receptor alpha antibody dupilumab: facing a new era in treating atopic dermatitis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; C | 2015 |
Drug survival for azathioprine and enteric-coated mycophenolate sodium in a long-term daily practice cohort of adult patients with atopic dermatitis.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Drug Resistance; Drug Substitution; Female; Humans; Kaplan- | 2016 |
Long-term Use of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Adults: A Monocentric Retrospective Study.
Topics: Adolescent; Adult; Aged; Azathioprine; Cyclosporine; Dermatitis, Atopic; Drug Therapy, Combination; | 2016 |
Effectiveness of azathioprine pulse therapy in prolonging remission of psoriasis.
Topics: Azathioprine; Dermatitis, Atopic; Eczema; Humans; Psoriasis | 2017 |
Editorial on Guidelines for the Management of Atopic Dermatitis in Singapore.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclospori | 2016 |
Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study.
Topics: Adult; Aged; Ambulatory Care; Azathioprine; Case-Control Studies; Cyclosporine; Denmark; Dermatitis, | 2016 |
Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
Topics: Adult; Azathioprine; Canada; Child; Cyclosporine; Dermatitis, Atopic; Dermatology; Drug Prescription | 2017 |
Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
Topics: Adult; Alitretinoin; Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Dermatitis, Atopic; Femal | 2017 |
Further experience of using azathioprine in the treatment of severe atopic dermatitis.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Dermatitis, Atopic; Female; Follow-Up Studies; Humans; | 2008 |
Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.
Topics: Adolescent; Age Factors; Azathioprine; Child; Dermatitis, Atopic; Dose-Response Relationship, Drug; | 2009 |
Optimizing clinical use of azathioprine with newer pharmacogenetic data.
Topics: Azathioprine; Dermatitis, Atopic; Dose-Response Relationship, Drug; Drug Administration Schedule; Fe | 2009 |
TPMT*26 (208F-->L), a novel mutation detected in a Chinese.
Topics: Asian People; Azathioprine; Dermatitis, Atopic; Genotype; Humans; Immunosuppressive Agents; Male; Me | 2009 |
[Safety of azathioprine therapy adjusted to thiopurine methyltransferase activity in the treatment of infantile atopic dermatitis. Report on 7 cases].
Topics: Adolescent; Azathioprine; Child; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; | 2010 |
Acute pancreatitis and erythema nodosum associated with azathioprine.
Topics: Acute Disease; Azathioprine; Dermatitis, Atopic; Dermatologic Agents; Erythema Nodosum; Humans; Immu | 2012 |
Life threatening myelotoxicity secondary to azathioprine in a patient with atopic eczema and normal thiopurine methyltransferase activity.
Topics: Adult; Azathioprine; Bone Marrow Diseases; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Mal | 2011 |
Clinically integrated care. Shared care/blame arrangements.
Topics: Azathioprine; Bone Marrow Diseases; Dermatitis, Atopic; Drug Monitoring; Humans; Immunosuppressive A | 2011 |
Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring.
Topics: Administration, Oral; Adolescent; Azathioprine; Child; Child, Preschool; Dermatitis, Atopic; Female; | 2013 |
A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression.
Topics: Azathioprine; Biomarkers; Child; Child, Preschool; Dermatitis, Atopic; Drug Therapy, Combination; Er | 2002 |
[Drug-induced alveolitis associated with infliximab/azathioprine therapy].
Topics: Alveolitis, Extrinsic Allergic; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Derm | 2008 |
Hypereosinophilia, hyper-IgE syndrome, and atopic dermatitis in a toddler with food hypersensitivity.
Topics: Azathioprine; Bone Marrow Examination; Cell Separation; Combined Modality Therapy; Dermatitis, Atopi | 2008 |
Retrospective review of the use of azathioprine in severe atopic dermatitis.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Dermatitis, Atopic; | 1996 |
Kaposi's sarcoma during immunosuppressive therapy for atopic dermatitis.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Azathioprine; Betamethasone Valerate; CD4-P | 1997 |
Azathioprine in dermatology: a survey of current practice in the U.K.
Topics: Azathioprine; Bone Marrow; Dermatitis, Atopic; Dermatology; Drug Administration Schedule; Health Car | 1997 |
The use of azathioprine in severe adult atopic eczema.
Topics: Adult; Antimetabolites; Azathioprine; Clinical Trials as Topic; Dermatitis, Atopic; Drug Evaluation; | 1998 |
Treatment of common skin complaints--changing referral patterns.
Topics: Acne Vulgaris; Anthralin; Azathioprine; Dermatitis, Atopic; Dermatology; Diagnosis, Differential; Ec | 1997 |
Clinical improvement and significant reduction of total serum IgE in patients suffering from severe atopic dermatitis treated with oral azathioprine.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Azathioprine; Dermatitis, Atopic; Female; Huma | 2002 |
[Azathiopurine in treatment of atopic dermatitis and its influence to IgE level and various kinds of immunological tests (author's transl)].
Topics: Adult; Azathioprine; Dermatitis, Atopic; Humans; Immunoglobulin E; Male | 1975 |
Recurrent facial herpes associated with Chinese herbal remedy.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Drugs, Chinese Herbal; Facial Dermatoses; Herpes Simplex; H | 1991 |
The effect of some immunomodulating agents on the sensitization phase of experimental contact allergic reactions.
Topics: Animals; Azathioprine; Cyclophosphamide; Dermatitis, Atopic; Dermatitis, Contact; Dose-Response Rela | 1986 |
Immunoglobulin E in "healed" atopic dermatitis and after treatment with corticosteroids and azathioprine.
Topics: Adolescent; Adult; Aged; Azathioprine; Dermatitis, Atopic; Eczema; Female; gamma-Globulins; Humans; | 1970 |
Differential effect of immunosuppressive agents on T and B lymphocytes.
Topics: Animals; Antilymphocyte Serum; Azathioprine; B-Lymphocytes; Bacterial Infections; Concanavalin A; De | 1974 |